Angioscopic findings after drug-eluting stent implantation

Herz

Volumn 32, Issue 4, 2007, Pages 281-286

  Takano, Masamichi ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Drug; Neointima; Plaque; Stent; Thrombus

Indexed keywords

RAPAMYCIN;

ANGIOSCOPY; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY; CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; INFLAMMATION; INTIMA; INTRAVASCULAR CATHETER; INTRAVASCULAR ULTRASOUND; REVIEW;

ANGIOSCOPY; BLOOD VESSEL PROSTHESIS; DRUG IMPLANTS; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROSTHESIS DESIGN; PUBLIC POLICY; STENTS; THROMBOSIS; TREATMENT OUTCOME;

EID: 34447260891     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-2996-x     Document Type: Review

References (41)

1. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981-93.
2. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43.
3. Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
4. Kiemeneij F, Serruys PW, Macaya C, et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol 2001;37:1598-603.
5. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-54.
6. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002;39:183-93.
7. Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contribution of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30.
8. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
9. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-62.
10. Chung IM, Gold HK, Schwartz SM, et al. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002;40:2072-81.
11. Glover C, Ma X, Chen YX, et al. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 2002;89:702-9.
12. Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001;104:852-5.
13. Morice JW, Serruys PW, Sousa JE, et al., for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
14. Moses JW, Leon MB, Popma JJ, et al., for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
15. Schofer J, Schluter M, Gershlick AH, et al., for the E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial. Lancet 2003;362:1093-9.
16. Schampaert E, Cohen EA, Schluter M, et al., for the C-SIRIUS Investigators. The Canadian study of sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-5.
17. Degertekin M, Lemos PA, Lee CH, et al. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J 2004;25:32-8.
18. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004;109:2273-8.
19. Saia F, Lemos PA, Lee CH, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Circulation 2003;108:1927-9.
20. Serruys PW, Degertekin M, Tanabe K, et al., for the RAVEL Study Group. Intravascular ultrasound findings in the multicenter randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
21. Sakai S, Mizuno K, Yokoyama S, et al. Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study. J Am Coll Cardiol 2003;42:1558-65.
22. Takano M, Mizuno K, Yokoyama S, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. J Am Coll Cardiol 2003;42:680-6.
23. Okamatsu K, Takano M, Sakai S, et al. Elevated troponin-T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation 2004;109:465-70.
24. Takano M, Inami S, Ishibashi F, et al. Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions. J Am Coll Cardiol 2005;45:652-8.
25. Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic morphology in patients with acute coronary disorders. Lancet 1991;337:809-12.
26. Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992;326:287-91.
27. Takano M, Mizuno K, Okamatsu K, et al. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 2001;38:99-104.
28. Ueda Y, Nanto S, Komamura K, et al. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994;23:341-6.
29. Asakura M, Ueda Y, Nanto S, et al. Remodeling of in-stent neointima, which become thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation 1998;97:2003-6.
30. Isner JM, Kearney M, Bortman S, et al. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91:2703-11.
31. Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108-11.
32. Takano M, Ohba T, Inami S, et al. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 2006;27:2189-95.
33. Oyabu J, Ueda Y, Ogasawara N, et al. Angioscopic evaluation of neointimal coverage of neointima coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006;152:1168-74.
34. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-8.
35. Takano M, Jang IK, Mizuno K. Neointimal proliferation around malapposed struts of a sirolimus-eluting stent: optical coherence tomography findings. Eur Heart J 2006;27:1763.
36. Takano M, Inami S, Jang IK, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007;99:1033-8.
37. McFadden E, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
38. Takano M, Mizuno K. Late coronary thrombosis in a sirolimus-eluting stent due to the lack of neointimal coverage. Eur Heart J 2006;27:1133.
39. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
40. Pfisterer M, Rocca PBL, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91.
41. Sousa JE, Costa MA, Abizaid A, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 2005;111:2326-9.